Literature DB >> 27492512

Nonspecific interstitial pneumonia preceding diagnosis of collagen vascular disease.

Masato Kono1, Yutaro Nakamura2, Katsuhiro Yoshimura3, Yasunori Enomoto3, Yoshiyuki Oyama3, Hironao Hozumi3, Noriyuki Enomoto3, Tomoyuki Fujisawa3, Naoki Inui3, Etsuko Hamada4, Thomas V Colby5, Masato Maekawa4, Takafumi Suda3.   

Abstract

BACKGROUND: The aim of this study was to evaluate the incidence and clinical features of patients who developed collagen vascular disease (CVD) after an initial diagnosis of idiopathic nonspecific interstitial pneumonia (NSIP).
METHODS: We conducted a retrospective review of 72 consecutive patients with NSIP who were diagnosed by surgical lung biopsy in our institution (idiopathic NSIP, n = 35; CVD-NSIP, n = 37 at initial diagnosis). No patients fulfilled the American College of Rheumatology criteria for a diagnosis with CVD within six months after the diagnosis of idiopathic NSIP.
RESULTS: Of 35 patients initially diagnosed with idiopathic NSIP, six patients (17.1%) developed CVD during the follow-up period (5.5 ± 5.0 years); three patients were diagnosed with dermatomyositis (DM), two patients with overlap syndrome (DM and Sjogren's syndrome), and one patient with rheumatoid arthritis. The mean time until CVD diagnosis was 2.0 years (six months - 3.5 years), and the one-, two- and three-year incidences of CVD development were 3.6%, 15.2% and 20.0%, respectively. There was no significant difference in clinical characteristics and survival among patients with NSIP preceding CVD diagnosis, those with idiopathic NSIP, or those with CVD-NSIP. In addition, at the time of initial diagnosis, there was no significant difference for the fulfillment of previous criteria such as interstitial pneumonia with autoimmune feature (IPAF) between patients with NSIP preceding CVD diagnosis and those with idiopathic NSIP.
CONCLUSIONS: It is difficult to predict CVD occurrence and careful attention is needed to detect the development of CVD in patients with idiopathic NSIP.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Collagen vascular disease (CVD); Connective tissue disease (CTD); Idiopathic interstitial pneumonias (IIPs); Interstitial pneumonia with autoimmune features (IPAF); Nonspecific interstitial pneumonia (NSIP)

Mesh:

Substances:

Year:  2016        PMID: 27492512     DOI: 10.1016/j.rmed.2016.05.030

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  11 in total

1.  Interstitial Pneumonia with Autoimmune Features: Overview of proposed criteria and recent cohort characterization.

Authors:  Cathryn T Lee; Justin M Oldham
Journal:  Clin Pulm Med       Date:  2017-09

2.  Interstitial Lung Disease Associated with Connective Tissue Diseases.

Authors:  Ruben A Peredo; Vivek Mehta; Scott Beegle
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Central paradiaphragmatic middle lobe involvement in nonspecific interstitial pneumonia.

Authors:  Joanna G Escalon; Alan C Legasto; Dennis Toy; James F Gruden
Journal:  Eur Radiol       Date:  2021-02-23       Impact factor: 5.315

4.  The Onset of Eosinophilic Pneumonia Preceding Anti-synthetase Syndrome.

Authors:  Yoshimasa Hachisu; Yasuhiko Koga; Noriaki Sunaga; Chiharu Kashiwagi; Yuri Sawada; Yasuyuki Saito; Yusuke Tsukagoshi; Norimitsu Kasahara; Reiko Sakurai; Hiroaki Tsurumaki; Masakiyo Yatomi; Kyoichi Kaira; Akihiro Ono; Toshitaka Maeno; Takeshi Hisada
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

5.  Systematic review and meta-analysis of clinical significance of autoantibodies for idiopathic pulmonary fibrosis.

Authors:  Hiroyuki Kamiya; Ogee Mer Panlaqui
Journal:  BMJ Open       Date:  2019-05-29       Impact factor: 2.692

Review 6.  Interstitial Pneumonia With Autoimmune Features (IPAF).

Authors:  Ligia Fernandes; Mouhamad Nasser; Kais Ahmad; Vincent Cottin
Journal:  Front Med (Lausanne)       Date:  2019-09-27

Review 7.  Interstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians.

Authors:  Elisabeth Bendstrup; Janne Møller; Sissel Kronborg-White; Thomas Skovhus Prior; Charlotte Hyldgaard
Journal:  J Clin Med       Date:  2019-11-21       Impact factor: 4.241

8.  Morphological and molecular motifs of fibrosing pulmonary injury patterns.

Authors:  Danny Jonigk; Helge Stark; Peter Braubach; Lavinia Neubert; Hoen-Oh Shin; Nicole Izykowski; Tobias Welte; Sabina Janciauskiene; Gregor Warnecke; Axel Haverich; Mark Kuehnel; Florian Laenger
Journal:  J Pathol Clin Res       Date:  2019-09-25

Review 9.  Interstitial lung disease pathology in systemic sclerosis.

Authors:  Kristine E Konopka; Jeffrey L Myers
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-07-17       Impact factor: 5.346

10.  International multidisciplinary team discussions on the diagnosis of idiopathic non-specific interstitial pneumonia and the development of connective tissue disease.

Authors:  Janne Møller; Alan Altraja; Tone Sjåheim; Finn Rasmussen; Line Bille Madsen; Elisabeth Bendstrup
Journal:  Eur Clin Respir J       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.